Skip to content
DraconiticResearch
Search Sources API
184,937 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY-NC 4.0Therapeutic Advances in Gastrointestinal Endoscopy

EUS-guided vascular therapy: an effective approach for refractory and per-endoscopic non-variceal gastrointestinal bleeding

Abstract

Background:: Endoscopic ultrasound (EUS) offers transparietal access to vascular structures, enabling localized treatment. Few studies have been published about EUS-guided vascular therapy, with a limited number of patients, especially in non-variceal bleeding. We present our results in this setting.

Objectives:: The primary objective was to evaluate the efficacy of EUS-guided vascular embolization, defined as the disappearance of both Doppler signal and bleeding. Secondary objectives were to document adverse events (AGREE classification), the rate of recurrences, and their management.

Design:: This was a single-center retrospective observational study.

Methods:: All patients included underwent EUS-guided vascular embolization for spontaneous or intraoperative non-variceal GI bleeding, using acrylic bioglue with Lipiodol as embolizing agent.

Results:: A total of 42 patients, aged between 31 and 88 years, were included (median 67.5). The origin of the bleeding was spontaneous on a pre-existing lesion in 59.5% of cases, and consecutive to an endoscopic procedure in 40.5% of cases. Initial technical and clinical success rates were 100%. No major adverse event was observed. Seven patients (16.7%) experienced a bleeding recurrence, with a median delay of 42 days [2–127], all in the spontaneous group. Five were managed by a second EUS-guided embolization, and one had a third recurrence managed surgically.

Conclusion:: This study underlines the major value of EUS-guided vascular approach in the treatment of recurrent and complex, as well as intraoperative GI bleedings, showing a high efficacy rate and good safety profile. Improvements in embolization techniques and devices would further democratize the procedure.

Related

  1. Tranexamic acid use and progression to clinically important bleeding in critically ill patients with non-clinically important non-variceal upper gastrointestinal bleeding: a retrospective cohort study
    Ji Luo, Zheng Lei, Yuanjun Zhang +8
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. The efficacy and safety of endoscopic ultrasound selective variceal devascularization for the treatment of esophagogastric varices: a retrospective cohort study.
    Chengqi Guan, Fan Huang, Hongyuan Shen +5
    BMC gastroenterologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
  3. Early Changes in Spleen Stiffness After Endoscopic Treatment Are Associated with Esophageal Variceal Recurrence: A Pilot Study
    Akira Uchiyama, Shunhei Yamashina, Satoshi Sakuma +8
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Day of Arrival as a Determinant of Endoscopy Timing in Non-Variceal Upper Gastrointestinal Bleeding: A Natural-Experiment Cohort Study of Clinical Outcomes and Length of Stay
    Lokman Bayram, Faruk Danış
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  5. Increasing Adoption Trends of Gastric Per-Oral Endoscopic Myotomy Over Gastric Electrical Stimulation for Refractory Gastroparesis: A Nationwide Analysis.
    Mohamed H Eldesouki, Youssef Hafez, Ahmed Ibrahim +3
    Gastro hep advancesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{irigoyen2026eusguided,
  title = {{EUS-guided vascular therapy: an effective approach for refractory and per-endoscopic non-variceal gastrointestinal bleeding}},
  author = {Alexis Irigoyen and Mohamed Gasmi and Marc Barthet and Jean-Michel Gonzalez},
  journal = {Therapeutic Advances in Gastrointestinal Endoscopy},
  year = {2026},
  month = sep,
  doi = {10.1177/26317745251405741},
  url = {https://doi.org/10.1177/26317745251405741},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - EUS-guided vascular therapy: an effective approach for refractory and per-endoscopic non-variceal gastrointestinal bleeding
AU  - Alexis Irigoyen
AU  - Mohamed Gasmi
AU  - Marc Barthet
AU  - Jean-Michel Gonzalez
PY  - 2026
DA  - 2026/09/17
JO  - Therapeutic Advances in Gastrointestinal Endoscopy
DO  - 10.1177/26317745251405741
UR  - https://doi.org/10.1177/26317745251405741
AB  - Background:: Endoscopic ultrasound (EUS) offers transparietal access to vascular structures, enabling localized treatment. Few studies have been published about EUS-guided vascular therapy, with a limited number of patients, especially in non-variceal bleeding. We present our results in this setting.  Objectives:: The primary objective was to evaluate the efficacy of EUS-guided vascular embolization, defined as the disappearance of both Doppler signal and bleeding. Secondary objectives were to document adverse events (AGREE classification), the rate of recurrences, and their management.  Design:: This was a single-center retrospective observational study.  Methods:: All patients included underwent EUS-guided vascular embolization for spontaneous or intraoperative non-variceal GI bleeding, using acrylic bioglue with Lipiodol as embolizing agent.  Results:: A total of 42 patients, aged between 31 and 88 years, were included (median 67.5). The origin of the bleeding was spontaneous on a pre-existing lesion in 59.5% of cases, and consecutive to an endoscopic procedure in 40.5% of cases. Initial technical and clinical success rates were 100%. No major adverse event was observed. Seven patients (16.7%) experienced a bleeding recurrence, with a median delay of 42 days [2–127], all in the spontaneous group. Five were managed by a second EUS-guided embolization, and one had a third recurrence managed surgically.  Conclusion:: This study underlines the major value of EUS-guided vascular approach in the treatment of recurrent and complex, as well as intraoperative GI bleedings, showing a high efficacy rate and good safety profile. Improvements in embolization techniques and devices would further democratize the procedure.
SN  - 2631-7745
ER  -